Other recorded roll call
HB766
House Vote on HB 766 CONCUR IN SENATE AMENDMENTS (#1694)
Provides relative to coverage for orally administered anti-cancer medications (EN +$66,367 SG EX See Note)
Passed
House
May 29, 2026
97Yea
0Nay
0Not voting
8Absent
Republicans (73)
100% yea among members casting a yea or nay vote (69–0).
Democrats (32)
100% yea among members casting a yea or nay vote (28–0).
Source provenance
- LegiScan roll-call ID
- 1703284
- LegiScan bill ID
- 2126170
- Session ID
- 2248
- Individual records rendered
- 105
- Source file
var/states/louisiana/source/legiscan/2248-129398a2968f/vote/1703284.json- Package observed
- 2026-08-07T15:15:47+00:00
- Final-action classification
- Did not match the final-vote patterns; retained as part of the complete bill record.